公告日期：2026-04-23

Company code: 603939 Company abbreviation: Yifeng Pharmacy
Yifeng Pharmacy Chain Co., Ltd.

2025 Annual Report

This report is prepared in both Chinese and English and is published electronically. If there is any
inconsistency between the two versions, the Chinese version shall prevail.

Important Notes

I. The Board of Directors, directors, and senior management of the Company hereby guarantee
that the contents are authentic, accurate, and complete, without false records, misleading
representations or material omissions in theAnnual Report, and shall take all the joint and several
legal liabilities.

II. All the directors have attended the meeting of the Board of Directors.

III. Pan-China Certified Public Accountants LLP has issued a standard unqualified audit report
for the Company.

IV. Gao Yi, the Company's responsible person, Gao Youcheng, responsible person in charge of
accounting work, and Guan Changfu, the accounting firm's responsible person (accounting
superintendent) hereby declare and warrant that the financial report in the Annual Report is
authentic, accurate, and complete.

V. The plan of profit distribution or the conversion of capital reserves into share capital for the
Reporting Period has been approved by the Board of Directors

As audited by Pan-China Certified Public Accountants LLP (special general partnership), the
undistributed profit of the Company (parent company basis) as of December 31, 2025 amounted to
CN¥775,719,439.87.

The Company proposes to distribute a cash dividend of CN¥0.40 (tax included) per share to all
shareholders. Based on the Company’s total share capital of 1,212,392,331 shares as of March 31, 2026,
the total proposed cash dividend amounts to CN¥484,956,932.40 (tax included). If the Company’s total
share capital changes during the period from the date of disclosure of this profit distribution plan to the
record date for the implem……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。